Want to join the conversation?
In 3Q16, $SHLM's EMEA segment reported net sales were $322.4MM, down 1.2% vs. 3Q15. Revenue fell due to lower volume in Commodity Distribution and Specialty Powders area. USCAN sales rose $46MM to $183.3MM due to Citadel's contribution of $57.9MM of engineered plastic revenues. Excluding acquisition, USCAN legacy sales fell 8.5%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?